Semzuvolimab is a human IgG1kappa antibody, targeting to p55, T cell surface antigen T4/Leu-3 (CD4). Human CD4 antibodies can neutralize HIV infection and have the potential to inhibit HAART stable HIV infection[1][2].
Molecular Weight:
(145.15 kDa)
Purity:
95.00
CAS Number:
[2409099-32-5]
Target:
HIV
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
